11 Aug 2022 argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis Member news
05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
21 Jun 2022 New agreement paves way for development of first African-owned COVID-19 vaccine Member news
31 May 2022 argenx announces the UK MHRA has granted early access to efgartigimod for generalized myasthenia gravis Member news
05 Apr 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Member news
17 Feb 2022 miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study Member news
09 Feb 2022 Medical device Morphemat® wins Gold ‘Business Innovation’ Henry van de Velde Award Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
